Evidence map›Paper›PMID 38250668›Full record

ArticleMDM policy & practice

Understanding Treatment Preferences for Patients with Tricuspid Regurgitation.

Vijay Iyer, Nadeen N Faza, Michael Pfeiffer, Mark Kozak, Brandon Peterson, Mortiz Wyler von Ballmoos, Sarah Mollenkopf, Melissa Mancilla, Diandra Latibeaudiere-Gardner, Michael J Reardon

Open access · goldAbstract read
In one paragraph

Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Vijay IyerDivision of Cardiology, Buffalo General Medical Center, Buffalo, NY, USA.
Nadeen N FazaHouston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Michael PfeifferDivision of Cardiology, Penn State Heart and Vascular Institute, Hershey, PA, USA.
Mark KozakDivision of Cardiology, Penn State Heart and Vascular Institute, Hershey, PA, USA.
Brandon PetersonDivision of Cardiology, Penn State Heart and Vascular Institute, Hershey, PA, USA.
Mortiz Wyler von BallmoosHouston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Sarah MollenkopfEdwards Lifesciences, Irvine, CA, USA.
Melissa MancillaEdwards Lifesciences, Irvine, CA, USA.ORCID https://orcid.org/0009-0008-5758-420X
Diandra Latibeaudiere-GardnerICON Clinical Research Limited, London, UK.
Michael J ReardonHouston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.
Houston Methodist · USPenn State Milton S. Hershey Medical Center · USEdwards Lifesciences (United States) · USBuffalo General Medical Center · USImperial Consultants · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Highlights: This study provides quantitative patient preference data from clinically confirmed tricuspid regurgitation (TR) patients to understand their treatment preferences.Using a targeted literature search and patient, physician, and Food and Drug Administration feedback, a cross-sectional survey with a discrete-choice experiment that focused on 5 of the most important attributes to TR patients was developed and administered online.TR patients are willing to accept higher procedural reintervention risk if shortness of breath is alleviated, and this risk tolerance is higher for older and more symptomatic patients.

Indexed as

discrete choice experimentpatient preferencetreatmenttricuspid regurgitation

Identifiers

PMID38250668
PMCPMC10798093
OpenAlexW4390987355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.